Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ELDRED KARY
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director FREEMAN KEVIN D
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director FREEMAN KEVIN D
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Zordani Richard A. Jr.
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jamil Khurram
Galectin Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Jamil Khurram
Galectin Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director ELDRED KARY
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ELDRED KARY
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director FREEMAN KEVIN D
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Zordani Richard A. Jr.
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LEWIS JOEL
Galectin Therapeutics | 5: Annual statement of changes in beneficial ownership of securities-10% Owner CZIRR JAMES C
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner CZIRR JAMES C
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director FREEMAN KEVIN D
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director FREEMAN KEVIN D
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LEWIS JOEL
Galectin Therapeutics | 3: Initial statement of beneficial ownership of securities-Director CARSON BENJAMIN SR
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Zordani Richard A. Jr.
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Uihlein Richard E
Galectin Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Schwartz Elissa J.
No Data
No Data